Vycor Medical Inc was Vycor Medical’s largest segment in fiscal 2025, bringing in $1.80M of $1.86M (96%).
| Segment | FY 2011 | FY 2012 | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vycor Medical Inc | — | — | $1.52M | $1.80M | |||||||||||
| Vycor Medical | $1.13M | $1.38M | — | — | |||||||||||
| Novavision | — | $82.01K | — | — | |||||||||||
| Nova Vision | $92.07K | — | — | — | |||||||||||
| Nova Vision Inc | — | — | $73.58K | $67.33K | |||||||||||
| Total | $1.22M | $1.46M | $1.59M | $1.86M |
Vycor Medical brought in $1.86M from its two segments in fiscal 2025, the year ended December 31, 2025. That was up 17.2% from $1.59M in fiscal 2024. Vycor Medical Inc was the largest at $1.80M (96.4%), ahead of Nova Vision Inc at $67.33K (3.6%).
Compared with fiscal 2024, Vycor Medical Inc grew 18.5% to $1.80M, while Nova Vision Inc fell 8.5% to $67.33K.
Vycor Medical began breaking out Vycor Medical Inc in fiscal 2024 and Nova Vision Inc in fiscal 2024. Vycor Medical stopped reporting Vycor Medical ($1.38M in fiscal 2023), Nova Vision ($92.07K in fiscal 2022) and Novavision ($82.01K in fiscal 2023) as separate segments.
United States was Vycor Medical’s largest region in fiscal 2025, bringing in $1.86M of $1.86M (100%).
| Geography | FY 2011 | FY 2012 | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $1.21M | $1.45M | $1.59M | $1.86M | |||||||||||
| Us | — | — | — | — | |||||||||||
| Europe | $8.27K | $6.71K | $3.68K | $4.91K | |||||||||||
| Total | $1.22M | $1.46M | $1.59M | $1.86M |
Vycor Medical brought in $1.86M from its two regions in fiscal 2025, the year ended December 31, 2025. That was up 17.2% from $1.59M in fiscal 2024. United States was the largest at $1.86M (99.7%), ahead of Europe at $4.91K (0.3%).
From fiscal 2022 to 2025, combined revenue from these regions grew from $1.22M to $1.86M, a compound annual growth rate of 15.1%. United States' share held steady at about 99.7%.
Vycor Medical (VYCO) reports its revenue by segment and by geography. In fiscal 2025, Vycor Medical Inc was its largest segment, bringing in $1.80M (96.4% of the total), followed by Nova Vision Inc at $67.33K (3.6%).
Vycor Medical Inc was Vycor Medical's largest segment in fiscal 2025, bringing in $1.80M, or 96.4% of the $1.86M total across its two segments.
United States was Vycor Medical's largest region in fiscal 2025, bringing in $1.86M, or 99.7% of the $1.86M total across its two regions.
Vycor Medical Inc grew faster than Nova Vision Inc in fiscal 2025, up 18.5% from $1.52M to $1.80M. Nova Vision Inc fell 8.5% to $67.33K.
Every figure comes from Vycor Medical's annual financial filings, as reported. Each line keeps the name Vycor Medical gives it, and years follow its fiscal calendar.
Vycor Medical's revenue by segment goes back to fiscal 2011, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.